<?xml version="1.0" encoding="UTF-8"?>
<p id="Par67">Each lot was released if the following specifications were met: cellularity 1–12 × 10
 <sup>6</sup> CD133
 <sup>+</sup> cells; purity (% of CD133
 <sup>+</sup> cells/CD45
 <sup>+</sup> cells) ≥ 80%; vitality ≥ 80%; endotoxin &lt; 0.5 EU/ml; and sterile. Cells were stored overnight, resuspended in 10 ml of physiological saline, aliquoted in a sterile polypropylene conical tube and packed by the manufacturer as a “ready-to-use” cell product. Based on our stability data [
 <xref ref-type="bibr" rid="CR17">17</xref>], cell suspensions were administered within 24 h from the lot release.
</p>
